1. Skip to navigation
  2. Skip to content
  3. Skip to secondary content



Latino Daily News

Sunday December 11, 2011

STUDY:  Breast Cancer Death Rates Higher for Latinas

STUDY:  Breast Cancer Death Rates Higher for Latinas

Photo: Breast Cancer More Deadly for Latinas

Click Here to Enlarge Photo

Hispanic women are more likely to die from breast cancer than non- Hispanic white women, according to research presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011.

Breast cancer is the most common cancer and is the second cause of cancer death in women in the United States. Incidence and survival rates vary by ethnicity, and previous research has demonstrated a trend toward poorer survival in Hispanic women.

From 1992 to 1996, Kathy D. Baumgartner PhD and colleagues conducted the New Mexico Women’s Health Study (NMWHS), a statewide, population-based, case-control breast cancer study that examined the difference between Hispanic and non-Hispanic white women for breast cancer risk. In all, 692 women with a first primary breast cancer participated.

Hispanic women were about 20 percent more likely to die from breast cancer than non- Hispanic white women, which is consistent with other reports, Baumgartner said. After adjusting for age, stage, lymph node involvement and estrogen receptor (ER) status, the researchers saw the risk drop considerably to almost equal that of non-Hispanic white women — suggesting that “the ethnic difference in breast cancer mortality may be mostly biologically based,” Baumgartner said.

In addition, Hispanic women who received chemotherapy were about 1.5 times more likely to die from breast cancer compared with non-Hispanic white women who received chemotherapy, after adjusting for age and the characteristics noted above.

“It is not clear how much of this ethnic difference in survival is due to socioeconomic factors influencing access to screening and treatment or to biological ones,” Baumgartner said. “Some studies suggest that Hispanic women are more likely to develop ER-negative tumors that are resistant to chemotherapy.”